Targeting Phosphatidylserine Enhances the Anti-tumor Response to Tumor-Directed Radiation Therapy in a Preclinical Model of Melanoma

Targeting Phosphatidylserine Enhances the Anti-tumor Response to Tumor-Directed Radiation Therapy in a Preclinical Model of Melanoma

Summary: Phosphatidylserine (PS) is exposed on the surface of apoptotic cells and is known to promote immunosuppressive signals in the tumor microenvironment (TME). Antibodies that block PS interaction with its receptors have been shown to repolarize the TME into a proinflammatory state. Radiation t...

Full description

Bibliographic Details
Main Authors: Sadna Budhu, Rachel Giese, Aditi Gupta, Kelly Fitzgerald, Roberta Zappasodi, Sara Schad, Daniel Hirschhorn, Luis Felipe Campesato, Olivier De Henau, Mathieu Gigoux, Cailian Liu, Gregory Mazo, Liang Deng, Christopher A. Barker, Jedd D. Wolchok, Taha Merghoub
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Cell Reports
Subjects:
phosphatidylserine
radiation therapy
PD-1
melanoma
immunotherapy
immune modulation
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124720316090

Internet

http://www.sciencedirect.com/science/article/pii/S2211124720316090

Similar Items